Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Boron neutron capture therapy using boronophenylalanine-fructose complex may kill
tumor cells without harming normal tissue.
PURPOSE: This phase II trial is studying how well boron neutron capture therapy using
boronophenylalanine-fructose complex works in treating patients with metastatic melanoma.
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC